ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНААхмадеева, Г.Н.,
Магжанов, Р.В.,
Таюпова, Г.Н.,
Байтимеров, А.Р.,
Хидиятова, И.М.,
Akhmadeeva, G.N.,
Magzhanov, R.V.,
Tayupova, G.N.,
Bajtimerov, A.R.,
Hidijatova, I.M. (2017) (TCAs), are considered to be possibly
effective. There are no clear recommendations for
treatment is the only method to clinically treat CE dysfunction; however, this
treatment strategy faces
for catastrophic ruptures and subarachnoid hemorrhages (SAH). Swift and
effective measures for diagnosis
Zivari-Ghader, Tayebeh,
Valioglu, Ferzane,
Eftekhari, Aziz,
Aliyeva, Immi,
Beylerli, Ozal,
Davran, Soodabeh,
Cho, William C.,
Beilerli, Aferin,
Khalilov, Rovshan,
Javadov, Sabzali (2024) of conventional
treatments for patients with central nervous system diseases. The blood-brain barrier prevents
biology. These factors contribute to the limited
effectiveness of current
treatment modalities and result